Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes
- PMID: 9348199
- DOI: 10.1210/endo.138.11.5473
Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes
Abstract
We examined the question of whether insulin activates protein kinase C (PKC)-zeta in L6 myotubes, and the dependence of this activation on phosphatidylinositol (PI) 3-kinase. We also evaluated a number of issues that are relevant to the question of whether diacylglycerol (DAG)-dependent PKCs or DAG-insensitive PKCs, such as PKC-zeta, are more likely to play a role in insulin-stimulated glucose transport in L6 myotubes and other insulin-sensitive cell types. We found that insulin increased the enzyme activity of immunoprecipitable PKC-zeta in L6 myotubes, and this effect was blocked by PI 3-kinase inhibitors, wortmannin and LY294002; this suggested that PKC-zeta operates downstream of PI 3-kinase during insulin action. We also found that treatment of L6 myotubes with 5 microM tetradecanoyl phorbol-13-acetate (TPA) for 24 h led to 80-100% losses of all DAG-dependent PKCs (alpha, beta1, beta2, delta, epsilon) and TPA-stimulated glucose transport (2-deoxyglucose uptake); in contrast, there was full retention of PKC-zeta, as well as insulin-stimulated glucose transport and translocation of GLUT4 and GLUT1 to the plasma membrane. Unlike what has been reported in BC3H-1 myocytes, TPA treatment did not elicit increases in PKCbeta2 messenger RNA or protein in L6 myotubes, and selective retention of this PKC isoform could not explain the retention of insulin effects on glucose transport after prolonged TPA treatment. Of further interest, TPA acutely activated membrane-associated PI 3-kinase in L6 myotubes, and acute effects of TPA on glucose transport were inhibited, not only by the PKC inhibitor, LY379196, but also by both wortmannin and LY294002; this suggested that DAG-sensitive PKCs activate glucose transport through cross-talk with phosphatidylinositol (PI) 3-kinase, rather than directly through PKC. Also, the cell-permeable, myristoylated PKC-zeta pseudosubstrate inhibited insulin-stimulated glucose transport both in non-down-regulated and PKC-depleted (TPA-treated) L6 myotubes; thus, the PKC-zeta pseudosubstrate appeared to inhibit a protein kinase that is required for insulin-stimulated glucose transport but is distinct from DAG-sensitive PKCs. In keeping with the latter dissociation of DAG-sensitive PKCs and insulin-stimulated glucose transport, LY379196, which inhibits PKC-beta (preferentially) and other DAG-sensitive PKCs at relatively low concentrations, inhibited insulin-stimulated glucose transport only at much higher concentrations, not only in L6 myotubes, but also in rat adipocytes, BC3H-1 myocytes, 3T3/L1 adipocytes and rat soleus muscles. Finally, stable and transient expression of a kinase-inactive PKC-zeta inhibited basal and insulin-stimulated glucose transport in L6 myotubes. Collectively, our findings suggest that, whereas PKC-zeta is a reasonable candidate to participate in insulin stimulation of glucose transport, DAG-sensitive PKCs are unlikely participants.
Similar articles
-
Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes.Endocrinology. 2000 Nov;141(11):4120-7. doi: 10.1210/endo.141.11.7766. Endocrinology. 2000. PMID: 11089544
-
Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.Biochem J. 1999 Feb 1;337 ( Pt 3)(Pt 3):461-70. Biochem J. 1999. PMID: 9895289 Free PMC article.
-
Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes.J Endocrinol. 2009 May;201(2):199-209. doi: 10.1677/JOE-09-0046. Epub 2009 Mar 9. J Endocrinol. 2009. PMID: 19273501
-
Insulin-sensitive phospholipid signaling systems and glucose transport. Update II.Exp Biol Med (Maywood). 2001 Apr;226(4):283-95. doi: 10.1177/153537020122600404. Exp Biol Med (Maywood). 2001. PMID: 11368419 Review.
-
Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes.Diabetologia. 2001 Jun;44(6):659-73. doi: 10.1007/s001250051675. Diabetologia. 2001. PMID: 11440359 Review.
Cited by
-
AMPK and Beyond: The Signaling Network Controlling RabGAPs and Contraction-Mediated Glucose Uptake in Skeletal Muscle.Int J Mol Sci. 2024 Feb 5;25(3):1910. doi: 10.3390/ijms25031910. Int J Mol Sci. 2024. PMID: 38339185 Free PMC article. Review.
-
Diabetic Endothelial Cell Glycogen Synthase Kinase 3β Activation Induces VCAM1 Ectodomain Shedding.Int J Mol Sci. 2023 Sep 14;24(18):14105. doi: 10.3390/ijms241814105. Int J Mol Sci. 2023. PMID: 37762417 Free PMC article.
-
PKCα Isoform Inhibits Insulin Signaling and Aggravates Neuronal Insulin Resistance.Mol Neurobiol. 2023 Nov;60(11):6642-6659. doi: 10.1007/s12035-023-03486-6. Epub 2023 Jul 20. Mol Neurobiol. 2023. PMID: 37470970
-
Diacylglycerol-evoked activation of PKC and PKD isoforms in regulation of glucose and lipid metabolism: a review.Lipids Health Dis. 2020 May 28;19(1):113. doi: 10.1186/s12944-020-01286-8. Lipids Health Dis. 2020. PMID: 32466765 Free PMC article. Review.
-
Glial Growth Factor 2 Regulates Glucose Transport in Healthy Cardiac Myocytes and During Myocardial Infarction via an Akt-Dependent Pathway.Front Physiol. 2019 Mar 27;10:189. doi: 10.3389/fphys.2019.00189. eCollection 2019. Front Physiol. 2019. PMID: 30971932 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous